How do you approach CLL in a patient not currently on treatment who has a solid tumor that requires treatment?
Do you worry about their marrow reserve and response to neulasta in terms of lymphocytosis and decreased ANC response?
2 Answers
Mednet MemberInvited Expert
Medical Oncology · Long Island Jewish Medical Center
Answered on
This is a very pertinent question for all of us who treat patients with CLL.
- Patients with CLL mostly are elderly in age.
- Second cancer occurs more often in one with CLL than in the population without CLL. These second cancers can be in any organ, but the frequent sites are skin, GI tract, and lung...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Medical Oncology · University of Texas MD Anderson Cancer Center
Answered on
Use of G-CSF is not an issue for patients with CLL and they tend to respond well to G-CSF.
Join for free or sign in to see the full answer